We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$14.7B
AUM Growth
-$6.7B
Cap. Flow
-$8.87B
Cap. Flow %
-60.4%
Top 10 Hldgs %
30.89%
Holding
537
New
135
Increased
77
Reduced
139
Closed
111

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$73.6M
2
HD icon
Home Depot
HD
+$56.9M
3
CTLT
CATALENT, INC.
CTLT
+$56.8M
4
EMR icon
Emerson Electric
EMR
+$55.2M
5
DOW icon
Dow Inc
DOW
+$35.3M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$378M
2
AAPL icon
Apple
AAPL
+$293M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$281M
4
BABA icon
Alibaba
BABA
+$218M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$183M

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 1.73%
3 Utilities 1.59%
4 Financials 1.34%
5 Industrials 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPS
276
Compass Pathways
CMPS
$1.78B
$1.88M 0.01%
189,407
– –
MRVL icon
277
Marvell Technology
MRVL
$187B
$1.86M 0.01%
+42,965
New +$1.81M
IMA
278
ImageneBio Inc
IMA
$64.9M
$1.83M 0.01%
44,083
– –
CTMX icon
279
CytomX Therapeutics
CTMX
$750M
$1.79M 0.01%
1,188,225
-82,675
-7% -$187K
OLMA icon
280
Olema Pharmaceuticals
OLMA
$1.04B
$1.78M 0.01%
513,972
+18,672
+4% +$76.2K
PSTX
281
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.68M 0.01%
545,700
– –
ATOS icon
282
Atossa Therapeutics
ATOS
$23.7M
$1.61M 0.01%
148,387
– –
PNC icon
283
PNC Financial Services
PNC
$100B
$1.6M 0.01%
12,563
+8,480
+208% +$1.28M
THRX
284
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.6M 0.01%
179,619
– –
BMY icon
285
PUT
Bristol-Myers Squibb
BMY
$132B
$1.59M 0.01%
+23,000
New +$1.62M
INZY
286
DELISTED
Inozyme Pharma
INZY
$1.56M 0.01%
271,800
– –
IHS icon
287
IHS Holding
IHS
$2.79B
$1.54M 0.01%
175,673
-7,500
-4% -$56.1K
SCPH
288
DELISTED
scPharmaceuticals
SCPH
$1.5M 0.01%
165,000
– –
STTK icon
289
Shattuck Labs
STTK
$682M
$1.49M 0.01%
506,000
– –
MRVL icon
290
CALL
Marvell Technology
MRVL
$187B
$1.43M 0.01%
+33,000
New +$1.39M
HOWL icon
291
Werewolf Therapeutics
HOWL
$18.6M
$1.36M 0.01%
522,900
– –
LMT icon
292
Lockheed Martin
LMT
$139B
$1.33M 0.01%
+2,814
New +$1.32M
VIGL
293
DELISTED
Vigil Neuroscience
VIGL
$1.27M 0.01%
130,200
– –
ISEE
294
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.24M 0.01%
50,805
-1,095
-2% -$24K
LENZ
295
LENZ Therapeutics
LENZ
$168M
$1.23M 0.01%
71,871
-10,072
-12% -$163K
CRDF icon
296
Cardiff Oncology
CRDF
$80.1M
$1.19M 0.01%
722,100
– –
PRU icon
297
Prudential Financial
PRU
$42.1B
$1.16M 0.01%
+14,043
New +$1.34M
VIRX
298
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.11M 0.01%
698,000
– –
MPC icon
299
Marathon Petroleum
MPC
$90B
$1.06M 0.01%
+7,884
New +$986K
PSA icon
300
Public Storage
PSA
$60.8B
$1.06M 0.01%
+3,500
New +$1.03M
10 11
12
13 14

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

Laurion Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Laurion Capital Management held 537 positions worth $14.7B, down 31% from $21.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Laurion Capital Management withdrew a net $8.87B in Q1 2023, closing 111 positions and reducing 139 holdings. Its most notable exit was Amazon, an estimated $378M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 3.4% a quarter earlier, followed by Technology and Utilities.

Against the trend, Laurion Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $72.7M.

  • Laurion Capital Management's largest Q1 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 666,036 shares worth $72.7M.
  • Laurion Capital Management added most to Altimmune in Q1 2023, an estimated $32.7M increase.
  • Laurion Capital Management's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $65.9M.
  • Laurion Capital Management fully exited Amazon in Q1 2023, selling an estimated $378M.
  • Laurion Capital Management's ten largest holdings make up 31% of its $14.7B portfolio in Q1 2023.
  • Laurion Capital Management opened 135 new positions and closed 111 in Q1 2023.
  • Laurion Capital Management's portfolio value fell 31% quarter-over-quarter to $14.7B.

Based on Laurion Capital Management's 13F filing for Q1 2023, filed 15 May 2023.